Hormone Therapy

Early menopausal women experienced different changes in cognitive health imaging biomarkers based on route of delivery of hormone therapy vs. placebo in the Kronos Early Estrogen Prevention Study, according to a speaker.

A 1 mg dose of estradiol reduced biomarkers of inflammation tied to atherosclerosis in postmenopausal women — particularly those in early menopause — participating in the Early vs. Late Intervention Trial with Estradiol.

Fetal estrogens, considered “weak” steroid hormones detectable only during pregnancy, may improve the risk-benefit profile for the treatment of menopausal symptoms compared with current therapies, according to a speaker.

COVID-19 may increase the risk for blot clots in women who are pregnant or taking estrogen with birth control or hormone therapy, and more research is needed on the underlying mechanisms that could potentially drive risk, researchers wrote.

Cardiologists should consider a woman’s menopause status when assessing their CV risk, according to a presentation at the virtual American Society for Preventive Cardiology Congress on CVD Prevention.

A cohort of healthy women who underwent unsuccessful in vitro fertilization experienced increases in fasting glucose and insulin at 12 weeks that were not observed among similar women who became pregnant, study data show.

Women with primary ovarian insufficiency prescribed combined oral contraceptives experienced an increase in bone density at the lumbar spine and total femur compared with similar women prescribed other hormone formulations or no treatment.

A group of women exposed to female hormone therapy did not experience an increased rate of retinal vein occlusion or retinal artery occlusion compared with those with no exposure to female hormone therapy.

Transgender patients who receive sex reassignment surgery with dermatologic intervention had an increase in quality of life, according to a poster presented at the American Academy of Dermatology virtual meeting.

Medical schools around the country are trying to implement instruction in transgender care into their curriculum. Infectious Diseases in Children asked Katherine L. Margo, MD, emeritus associate professor of family medicine and community health at the University of Pennsylvania Perelman School of Medicine, if transgender health education should be required in medical school curricula.